We’ve joined investors and techies alike at the OurCrowd Investor Summit in Jerusalem, where Micah Tapman, among others, spoke about his vision for …
In an interview at the OurCrowd Investor Summit, Kfir Kachlon, the investment principal and cannabis tech lead for OurCrowd, opens up about how he …
Former Goldman Sachs Managing Director Andrew Pucher joins Tilray to lead the company’s global corporate development activity, including M&A and corporate investments
The cannabis carnival continues. As we’ve pointed out these past few weeks, Jefferies analyst Owen Bennett seems to have developed an interest in cannabis … …
Tilray or not Tilray, that is the question (and Jefferies chooses “not”)
Aurora Cannabis (ACB) announced that it has commenced sales of cannabis oils to German pharmacies following receipt of all necessary approvals from the …
National Access Cannabis Provides Sales Update for Retail Cannabis Operations since Federal Legalization
Following in the footsteps of Jefferies, which initiated Aurora Cannabis (ACB) with a “buy” rating last week, this week Cowen analyst Vivien Azer initiated …
FDA commissioner Scott Gottlieb announced yesterday that he would be retiring after nearly two years in the role. Seaport analyst Brett Hundley believes his departure …
Recognizing the potential associated with making marijuana more accessible, cannabis companies are researching edibles that include cannabis extracts as ingredients. The potential to reach …
